|
DynPort Vaccine Company LLC, a CSC company, is a technology integrator providing solutions that protect humanity from emerging threats. DVC has comprehensive experience in the advanced development of biodefense biologics, including live attenuated vaccines, recombinant vaccines, therapeutics, therapeutic polyclonal antibodies and alternative vaccine delivery systems. The DVC pipeline includes botulinum polyclonal antibodies, butyrylcholinesterase ("BioScavenger"), and vaccines for plague, tularemia, botulinum neurotoxin and seasonal and pandemic influenza. For more information and current career opportunities, visit www.csc.com/dvc.
^
|
|
|
Gold sponsor:
Silver sponsors:
Documentation
Click here to review a comprehesive list of presentations given at Phacilitate's previous 19 Forums. All documentation is available to purchase.
|
|
